Search results
Results from the WOW.Com Content Network
The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 ...
The New York City Department of Health and Mental Hygiene tweeted an update on vaccine availability Thursday. NEW Updated COVID-19 vaccines will be available in NYC within a few days.
The US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 vaccines to formulate their new shots to be a better match for the JN.1 lineage of the coronavirus.
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
On July 22, 2020, the U.S. government placed a conditional advance-purchase order of $2 billion with Pfizer to manufacture 100 million doses of a COVID-19 vaccine, with an option for 500 million more, for use in the United States if the vaccine was shown to be safe, effective, licensed, and authorized by the Food and Drug Administration (FDA).
AOL latest headlines, entertainment, sports, articles for business, health and world news.
In April 2021, the Indian Council of Medical Research reported that the vaccine has shown promising results in neutralising lineage B.1.617. [54] [55] In May 2021, a joint investigation by the scientists of the National Institute of Virology, found the vaccine effective in neutralising the Zeta variant or lineage P.2 (previously known as B.1.1. ...